Louie Janice K, Hacker Jill K, Mark Jennifer, Gavali Shilpa S, Yagi Shigeo, Espinosa Alex, Schnurr David P, Cossen Cynthia K, Isaacson Erin R, Glaser Carol A, Fischer Marc, Reingold Arthur L, Vugia Duc J
California Emerging Infections Program, California Department of Health Services, Berkeley, 94704, USA.
Emerg Infect Dis. 2004 Jun;10(6):1143-6. doi: 10.3201/eid1006.030863.
In California, molecular testing was useful in decreasing suspicion for severe acute respiratory syndrome (SARS), by detecting common respiratory pathogens (influenza A/B, human metapneumovirus, picornavirus, Mycoplasma pneumoniae, Chlamydia spp., parainfluenza virus, respiratory syncytial virus, and adenovirus) in 23 (45%) of 51 patients with suspected SARS and 9 (47%) of 19 patients with probable SARS.
在加利福尼亚州,分子检测通过在51例疑似严重急性呼吸综合征(SARS)患者中的23例(45%)以及19例可能感染SARS患者中的9例(47%)检测出常见呼吸道病原体(甲型/乙型流感病毒、人偏肺病毒、微小核糖核酸病毒、肺炎支原体、衣原体属、副流感病毒、呼吸道合胞病毒和腺病毒),有助于降低对SARS的怀疑。